Entry Point Capital, LLC Ocugen, Inc. Transaction History
Entry Point Capital, LLC
- $171 Million
- Q3 2024
A detailed history of Entry Point Capital, LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 65,174 shares of OCGN stock, worth $59,960. This represents 0.04% of its overall portfolio holdings.
Number of Shares
65,174Holding current value
$59,960% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding OCGN
# of Institutions
125Shares Held
78.3MCall Options Held
535KPut Options Held
523K-
Black Rock Inc. New York, NY17.9MShares$16.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.9MShares$15.6 Million0.0% of portfolio
-
State Street Corp Boston, MA15.8MShares$14.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.28MShares$5.78 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA2.45MShares$2.26 Million0.1% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $199M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...